Fresenius SE & Co. KGaA (FRE.XE) confirmed full-year
guidance after all business segments contributed to increased sales
in the third quarter.
Sales rose to 5.05 billion euros ($6.82 billion) in the third
quarter from EUR4.86 billion in the same period of the previous
year, and net profit increased to EUR265 million from EUR243
million.
Currency headwinds battered dialysis unit Fresenius Medical Care
AG & Co. KGaA's (FMS) nine-month sales, which increased by 3%
in currency-adjusted terms but 7% at constant rates. Units Kabi and
Vamed drove growth, with currency-adjusted sales up 11% and 22%,
respectively.
The group confirmed its 2013 profit and sales targets. In July,
the group lifted its full-year net profit outlook to between 11%
and 14% growth on the year in constant currency, compared with its
previous expectation of 7% to 12% growth.
The company didn't provide details on the integration of the
hospitals purchased from Rhoen-Klinikum AG (RHK.XE) this summer but
did say it expects the vast majority of the transaction to be
closed by the end of 2013. In September, Fresenius said it will pay
EUR3.07 billion for 43 hospitals in a deal that will make its
Helios unit the largest private hospital operator in Europe.
Write to Shane Strowmatt at shane.strowmatt@dowjones.com
Order free Annual Report for Fresenius SE & Co. KGaA
Visit http://djnweurope.ar.wilink.com/?ticker=DE0005785604 or
call +44 (0)208 391 6028
Order free Annual Report for Fresenius Medical Care AG & Co.
KGaA
Visit http://djnweurope.ar.wilink.com/?ticker=DE0005785802 or
call +44 (0)208 391 6028
Order free Annual Report for Rhön-Klinikum AG
Visit http://djnweurope.ar.wilink.com/?ticker=DE0007042301 or
call +44 (0)208 391 6028
Order free Annual Report for Fresenius Medical Care AG & Co.
KGaA
Visit http://djnweurope.ar.wilink.com/?ticker=US3580291066 or
call +44 (0)208 391 6028
Order free Annual Report for Fresenius SE & Co. KGaA
Visit http://djnweurope.ar.wilink.com/?ticker=US35804M1053 or
call +44 (0)208 391 6028
Order free Annual Report for Rhön-Klinikum AG
Visit http://djnweurope.ar.wilink.com/?ticker=US76240P1049 or
call +44 (0)208 391 6028
Subscribe to WSJ: http://online.wsj.com?mod=djnwires